Ratnakar Securities

Mobile Trading
COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE12824.3582.25 (+0.65 %)
PREV CLOSE ( ) 12742.10
OPEN PRICE ( ) 12749.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 587
TODAY'S LOW / HIGH ( )12730.00 13085.05
52 WK LOW / HIGH ( )5557 18089.55
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 07-01 1984
Management Info
Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director
Registered Office

Address 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone 040-67611600 / 67611700

Email neuland@neulandlabs.com

Website www.neulandlabs.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
 Listing : BSE, NSE
NEWS
27Feb Neuland Laboratories informs about dis
Neuland Laboratories has informed that the exchange has received the dis..
25Feb Neuland Laboratories informs about dis
Neuland Laboratories has informed that the exchange has received the dis..
22Jan Neuland Laboratories leads the gainers
Neuland Laboratories is currently trading at Rs. 13838.00, up by 641.95..
03Jan Neuland Laboratories informs about cer
Neuland Laboratories has informed that it enclosed certificate as requir..
24Dec Neuland Laboratories informs about upd
Pursuant to Company’s Insider Trading Code read with SEBI PIT Regulati..
MORE
Financials
in Millions
QTR Dec 24 ANNUAL 24
Net Profit1013.942995.96
Gross Profit 1275.45 4007.69
Operating Profit 902.824744.65
Net Sales 3980.3215585.8
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
up  8749.25 (2.80%)
M.Cap ( in Cr)21873.13
SMS Lifesciences (BSE)
up  1431.30 (12.48%)
M.Cap ( in Cr)432.72
Emcure Pharma (BSE)
up  1094.65 (9.13%)
M.Cap ( in Cr)20741.79
Mankind Pharma (BSE)
up  2582.65 (2.39%)
M.Cap ( in Cr)106554.59
Ajanta Pharma (BSE)
up  2695.10 (2.28%)
M.Cap ( in Cr)33665.06
MORE
Shareholding Pattern
MUTUAL FUNDS/UTI 7.43%
NON-INSTITUTION 33.84%
PROMOTERS 32.68%
FI/BANKS/INSURANCE 0.96%
GOVERNMENT 0.4%
FII 0%
MORE
Mf Holdings
MORE
FAQs
079-49005200 / 01 / 02
info@ratnakarsecurities.com
Download Mobile App

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
products
about us
usefull links
news room

Ratnakar Securities Pvt. Ltd. : SEBI Registration No. of NSE, BSE : INZ000191735 | SEBI Registration No. of NSDL : IN-DP-NSDL-66-88
Ratnakar Commodities Pvt. Ltd : SEBI Registration No. of MCX & NCDEX : INZ000024138
Investor Grievance ID : investorgrievance@ratnakarsecurities.com
Online Dispute Resolution Portal - SMART ODR
To File A Complaint on SCORES Click Here
To Close Account, Please Click Here
For Nomination, Please Click Here
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.